Factors associated with partial Mayo Clinic Score over time in patients with Ulcerative Colitis treated with filgotinib in the phase 2b/3 SELECTION trial

被引：0
|
作者：
Peyrin-Biroulet, L. [1 ,2 ]
Louis, E. [3 ]
Hisamatsu, T. [4 ]
Jamoul, C. [5 ]
Santermans, E. [5 ]
Harris, K. [6 ]
de Haas, A. [7 ]
Oortwijn, A. [8 ]
Feagan, B. [9 ]
机构：
[1] Hop Brabois, Dept Gastroenterol, Vandoeuvre Les Nancy, France
[2] Inserm, U954, Vandoeuvre Les Nancy, France
[3] Univ Hosp Liege, Dept Gastroenterol, Liege, Belgium
[4] Kyorin Univ, Dept Gastroenterol & Hepatol, Sch Med, Tokyo, Japan
[5] Galapagos NV, Biostat Dept, Mechelen, Belgium
[6] Galapagos NV, Med Evidence Generat Dept, Milan, Italy
[7] Galapagos NV, Clin Dev Dept, Leiden, Netherlands
[8] Galapagos NV, Med Affairs Dept, Leiden, Netherlands
[9] Western Univ, Div Gastroenterol, London, ON, Canada
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P736
引用
收藏
页码：866 / 866
页数：1
相关论文
共 39 条
  • [1] EARLY ACHIEVEMENT OF PARTIAL MAYO SCORE REMISSION AND IBDQ NORMALIZATION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FILGOTINIB IN THE PHASE 2B/3 SELECTION STUDY
    Vermeire, Severine
    Oortwijn, Alessandra
    Feagan, Brian G.
    Yun, Chohee
    Zhang, Jie
    Peyrin-Biroulet, Laurent
    Ferrante, Marc
    Danese, Silvio
    GASTROENTEROLOGY, 2021, 160 (06) : S352 - S353
  • [2] Efficacy of filgotinib in patients with Ulcerative Colitis by line of therapy in the phase 2b/3 SELECTION trial
    Peyrin-Biroulet, L.
    Dotan, I.
    Hibi, T.
    Thliadouros, V.
    Oortwijn, A.
    Zhao, S.
    Zhang, J.
    Hsieh, J.
    Feagan, B.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S024 - S025
  • [3] Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial
    Dotan, Iris
    Feagan, Brian G.
    Taliadouros, Virginia
    Oortwijn, Alessandra
    Rudolph, Christine
    de Haas, Angela
    Santermans, Eva
    Hsieh, Jeremy
    Peyrin-Biroulet, Laurent
    Hibi, Toshifumi
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (08): : 1207 - 1216
  • [4] Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial
    Danese, Silvio
    Ferrante, Marc
    Feagan, Brian G.
    Peyrin-Biroulet, Laurent
    Hibi, Toshifumi
    Sandborn, William J.
    Schreiber, Stefan
    Ritter, Timothy
    Loftus, Edward V.
    Rogler, Gerhard
    Oortwijn, Alessandra
    Yun, Chohee
    Le Brun, Franck-Olivier
    Dinoso, Jason
    Hsieh, Jeremy
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (01): : 138 - 147
  • [5] FILGOTINIB EFFICACY IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY: PHASE 2B/3 SELECTION RESULTS
    Morison, Ben
    Peyrin-Biroulet, Lauren
    Dotan, Iris
    Hibi, Toshifumi
    Taliadouros, Virginia
    Oortwijn, Alessandra
    Zhao, Sally
    Zhang, Jie
    Hsieh, Jeremy
    Feagan, Brian
    GUT, 2021, 70 : A5 - A6
  • [6] Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial (vol 17, pg 1207, 2023)
    Dotan, Iris
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (02): : 335 - 335
  • [7] SAFETY ANALYSIS OF FILGOTINIB FOR ULCERATIVE COLITIS: PHASE 2B/3 SELECTION STUDY AND LONGTERM EXTENSION RESULTS
    Morison, Ben
    Schreiber, Stefan
    Watanabe, Mamoru
    Yun, Chohee
    Zhou, Yan
    Zhao, Sally
    Hsieh, Jeremy
    Moerch, Ulrik
    Rogler, Gerhard
    Loftus, Edward V.
    GUT, 2021, 70 : A6 - A6
  • [8] Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study
    Watanabe, Kenji
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Fujitani, Yasushi
    Faes, Margaux
    Oortwijn, Alessandra
    Lindsay, James O.
    Rogler, Gerhard
    Hibi, Toshifumi
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (06): : 801 - 811
  • [9] Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studies
    Schreiber, S.
    Loftus, E. V., Jr.
    Maaser, C.
    Danese, S.
    Rudolph, C.
    Jongen, R.
    De Haas, A.
    Oortwijn, A.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I085 - I087
  • [10] EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY AGE: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION AND SELECTIONLTE STUDIES
    Schreiber, Stefan
    Loftus, Edward V.
    Maaser, Christian
    Danese, Silvio
    Rudolph, Christine
    Jongen, Rob
    de Haas, Angela
    Oortwijn, Alessandra
    Vermeire, Severine
    GASTROENTEROLOGY, 2022, 162 (07) : S633 - S634
1234